McKinsey & Company and Ropes & Gray life sciences partner Katherine Wang (Shanghai) has co-authored a white paper on partnering for innovation as companies respond to new requirements under China’s medical technology regulatory regime.
To meet China Food and Drug Administration guidelines, local and multinational MedTech companies in China must now upgrade device safety and effectiveness for medical products at each life cycle stage. The document addresses regulatory reform partnership strategy for local and multinational MedTech companies in China under new rules and increased enforcement.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.